Biofrontera BFRI
NASDAQ BFRI
$0.80 0.00 (-0.50%)
At close: Oct 21, 2026 · 4:00 PM EDT

Biofrontera (BFRI) Debt Ratio (2023 - 2024)

Updated

Biofrontera's Debt Ratio came in at 0.01 for Q2 2024, down 85.7% from the prior quarter.

Analysis

Biofrontera (BFRI) Debt Ratio (2023 - 2024) Analysis & Trends

For FY2023, Biofrontera's Debt Ratio was 0.14.

  • Business Quant data shows BFRI's Debt Ratio at 0.10 (Q1 2024), 0.14 (Q4 2023) and 0.05 (Q3 2023) in the three quarters before Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Biofrontera 10.34 Mn -11.45 Mn 9.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 0.01
Mar 31, 2024 0.10
Dec 31, 2023 0.14
Sep 30, 2023 0.05
API Access

Biofrontera Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=BFRI&period=max&api_key=YOUR_API_KEY